Litcius/Paper detail

Advances in Targeting ACE2 for Developing COVID-19 Therapeutics

Sanika Suvarnapathaki, Divya Chauhan, Angelina Nguyen, Murugan Ramalingam, Gulden Camci‐Unal

2022Annals of Biomedical Engineering21 citationsDOIOpen Access PDF

Topics & Concepts

Angiotensin-converting enzyme 2ReceptorCoronavirus disease 2019 (COVID-19)TMPRSS2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirusPandemicViral entryCoronavirusComputational biologyBiologyVirologyMedicineBioinformaticsViral replicationGeneticsDiseasePathologyInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCancer, Stress, Anesthesia, and Immune Response
Advances in Targeting ACE2 for Developing COVID-19 Therapeutics | Litcius